Arrowhead Pharma (ARWR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Sales | 650 | 3,510 | 8,714 | 9,343 | 8,986 |
| Gross Profit | 650 | 3,510 | 8,714 | 9,343 | 8,986 |
| Operating Expenses | 15,684 | 17,323 | 18,964 | 15,057 | 15,116 |
| Operating Income | -15,034 | -13,813 | -10,250 | -5,714 | -6,130 |
| Other Income | 150 | 615 | -479 | 195 | 87 |
| Pre-tax Income | -14,884 | -13,199 | -10,730 | -5,520 | -6,043 |
| Net Income Continuous | -14,884 | -13,199 | -10,732 | -5,520 | -6,043 |
| Net Income | $-14,884 | $-13,199 | $-10,732 | $-5,520 | $-6,043 |
| EPS Basic Total Ops | -0.18 | -0.18 | -0.15 | -0.07 | -0.08 |
| EPS Basic Continuous Ops | -0.18 | -0.18 | -0.14 | -0.07 | -0.08 |
| EPS Diluted Total Ops | -0.18 | -0.18 | -0.15 | -0.07 | -0.08 |
| EPS Diluted Continuous Ops | -0.18 | -0.18 | -0.14 | -0.07 | -0.08 |
| EBITDA(a) | $-13,642 | $-12,564 | $-8,999 | $-4,627 | $-5,006 |